Recruiting Breast Cancer Studies in Albuquerque
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)...
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC
The purpose of this study is to evaluate the safety and efficacy of the three-drug combination of tucatinib, trastuzumab, and eribulin in patients with de novo and recurrent unresectable metastatic HE...
About Breast Cancer Clinical Trials in Albuquerque
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Albuquerque, NM. These studies are seeking a combined 100 participants. Research is being sponsored by Criterium, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Albuquerque — FAQ
Are there breast cancer clinical trials in Albuquerque?
Yes, there are 2 breast cancer clinical trials currently recruiting in Albuquerque, NM. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Albuquerque?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Albuquerque research site will contact you about next steps.
Are clinical trials in Albuquerque free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Albuquerque studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Albuquerque are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov